| |||||||||

Revenue by Geography (USD) Annual | ||||||||
|---|---|---|---|---|---|---|---|---|
| FISCAL YEAR ENDING |
|
31-DEC 2004 |
31-DEC 2005 |
31-DEC 2006 |
31-DEC 2007 |
31-DEC 2008 |
||
| Revenue - International | 5.19B | 5.61B | 6.19B | 6.39B | 18.4B | |||
| Revenue - US | 4.66B | 9.57B | 9.97B | 9.47B | 0 | |||
| Total Revenue | 20.4B | 33.7B | 38.9B | 42.7B | 40.1B | |||
Revenue by Segment (USD) Annual | ||||||||
|---|---|---|---|---|---|---|---|---|
| FISCAL YEAR ENDING |
|
31-DEC 2004 |
31-DEC 2005 |
31-DEC 2006 |
31-DEC 2007 |
31-DEC 2008 |
||
| Revenue - Vaccines | 0 | 0 | 0 | 0 | 2.86B | |||
| Revenue - Other Products | 0 | 0 | 0 | 0 | 8.05B | |||
| Revenue - Plavix | 0 | 0 | 0 | 0 | 2.62B | |||
| Revenue - Lovenox | 0 | 0 | 0 | 0 | 2.74B | |||
| Revenue - Lantus | 0 | 0 | 0 | 0 | 2.45B | |||
| Revenue - Taxotere | 0 | 0 | 0 | 0 | 2.03B | |||
| Revenue - Eloxatine | 0 | 0 | 0 | 0 | 1.35B | |||
| Revenue - Allegra | 0 | 0 | 0 | 0 | 688M | |||
| Revenue - Copaxone | 0 | 0 | 0 | 0 | 622M | |||
| Revenue - Tritace | 0 | 0 | 0 | 0 | 513M | |||
| Revenue - Amaryl | 0 | 0 | 0 | 0 | 387M | |||
| Revenue - Xatral | 0 | 0 | 0 | 0 | 331M | |||
| Revenue - Actonel | 0 | 0 | 0 | 0 | 330M | |||
| Revenue - Depakine | 0 | 0 | 0 | 0 | 329M | |||
| Revenue - Nasacort | 0 | 0 | 0 | 0 | 241M | |||
| Total Revenue | 20.4B | 33.7B | 38.9B | 42.7B | 40.1B | |||
| ||||||